Wow .. Funny how we were just talking about J.R. in my other thread and our wish that he have WLS. Looks like he has made great progress w/o it, by going the diet and exercise route, the former helped greatly by having a personal chef at his disposal. Hope he keeps it up and keeps it off .. ! (and, again, gets those tats off his head )

https://www.aol.com/jelly-rolls-chef-opens-singers-155500931 .html

O.K., mystery solved. Apparently Amanda Halterman is another sister of Tammy Slaton and Amy Slaton-Halterman, if I'm reading this right. I'm still not sure whether "Halterman" or "Slaton" is the married name or the maiden name ... They are all three on the show .. Can anyone sort it out for us? Since the ex- of Amy is named "Halterman", I take it the maiden name is Slaton.

https://discovery-inc.fandom.com/wiki/Amanda_Halterman_(1000 -lb_Sisters)

Much more recently (just a few days ago, in fact) Tammy reveals her new hair style in the article (and short video) below .. btw, I was not aware that Tammy had undergone a failed RNY before .. Her current success is due to a revision to same. Her sister, Misty (Wentworth), actually underwent the SADI-S procedure. Supposedly Misty is doing well as a post op and is following her WLS "rules" also, per Tammy.

https://people.com/1000-lb-sisters-tammy-slaton-gets-haircut -tinashe-nasty-8691630

Speaking of which, a recent article (written by a WLS surgeon - Dr. Jawad) about how to avoid cross/transfer addictions following WLS:

https://www.orlandohealth.com/content-hub/have-you-had-baria tric-surgery-heres-how-to-avoid-new-addictions#:~:text=But%2 0some%20bariatric%20patients%20transfer,process%20addiction% 20or%20habit%20swap.

Oh great .. just what we needed, NOT:

https://www.aol.com/lifestyle/happens-clean-eating-goes-too- 100000555.html

Wow .. keep it up, Tammy!

https://www.usmagazine.com/celebrity-body/news/1000-lb-siste rs-tammy-shows-off-400-lb-weight-loss-in-swimsuit-pic/

Here is the latest .. an article about the injectables in The New York Times just released today. Seems to be putting a bit of a positive spin on the drug of late, including that it now supposedly helps those with sleep apnea .. (well, duh .. wouldn't weight loss itself tend to do that, with ob. apnea? ) It seems to be supposedly a panacea for a lot of ills (esp. those obesity-related), and those type of claims make me skeptical ..

* * * * * *

The new panacea?

	By Dani Blum I've covered Ozempic and similar drugs since 2022.

In the past two years, Ozempic has become a synonym for weight loss. When celebrities slimmed down, tabloids wondered whether they were taking the drug. Activists argued that the drug entrenched old norms about body image -- people still seemed to want to be thin. Ozempic was weight loss; weight loss was Ozempic. It's like Kleenex or Scotch tape: totemic.

Technically, while Ozempic is a diabetes drug, people can, and do, take it to drop weight.

But the drug -- and others in its class, such as Wegovy, Mounjaro and Zepbound -- is about much more. Scientists believe the drugs are about to revolutionize several fields of medicine, such as cardiology and endocrinology. Researchers are also running dozens of trials to see whether they might help with Alzheimer's, liver disease, polycystic ovary syndrome and even skin conditions. If these trials prove successful, the drugs may extend many lives by years, save billions in medical costs and divide public health into before-and-after epochs. A researcher studying these drugs told me he felt like the scientist who first discovered antibiotics.

Those are some sky-high hopes, and not all will be come true. But we've already seen a real-world impact. In March, the Food and Drug Administration said that doctors could use Wegovy to reduce the risk of heart problems. Last month, a trial showed that the compound in Ozempic reduced the risk of complications from chronic kidney disease. And last week, two trials found that tirzepatide, the substance in Mounjaro and Zepbound, could improve symptoms of sleep apnea.

The idea that a single drug that could target so many kinds of disease might sound too good to be true. These drugs, called GLP-1s (glucagon-like peptide 1 receptor agonists), mystify even the scientists who study them. When I asked researchers how it was possible that Ozempic might help with cognitive issues and nonalcoholic fatty liver disease and opioid addiction, they gave the same answer: We don't know!

But we have early clues about where these drugs might take us -- and what that means for medicine. In today's newsletter, I'll explain.

Ozempic injection pens on the production line. Charlotte de la Fuente for The New York Times

Fighting inflammation

Some researchers think Ozempic and drugs like it may have something of a medical superpower: lowering inflammation in the body.

Inflammation is a key part of the body's defense system. When we sense a threat, such as one posed by a pathogen, our cells work to help us fight off the intruder. But chronic inflammation contributes to heart disease, lung disease, diabetes and a host of other major illnesses. If new obesity drugs really do reduce inflammation, that could explain their effect across such a wide spectrum of diseases.

Still, there are already limits. Not everyone responds to GLP-1s. Even those who slim down inevitably hit a floor, typically after losing about 15 percent of their body weight. And the drugs come with side effects (nausea, vomiting, diarrhea and constipation) and rare but serious risks: People can develop gallstones and an inflamed pancreas; they can eat so little they become malnourished; and, more commonly, they can lose muscle mass.

Limiting urges

We know that these medications target the areas of the brain that regulate appetite. But there are questions around what else the drugs do to the mind. I've interviewed dozens of people taking these medications who say they've lost all interest in alcohol.

Could these drugs curb other compulsive behavior, too, the way they silence "food noise"? Studies in rats suggest that GLP-1s reduce cravings for cocaine. Scientists are examining whether these medications might even be able to alleviate gambling addictions and smoking.

The great experiment

Ozempic and drugs like it are considered "forever drugs" -- that is, people are supposed to stay on them for the rest of their lives. They're like statins or blood pressure medications. When you stop taking them, they stop working.

A display at a GNC store. Maansi Srivastava/The New York Times

But this class of drugs has existed for less than 20 years. Ozempic itself has been on the market for only six. We don't know what happens after lifelong use of these drugs. Researchers point to past examples of drugs we once thought were miraculous, chiefly fen-phen. It, too, was astonishingly effective for weight loss. Then doctors learned that it damaged the heart and stopped prescribing it.

It will take years, more diverse trials and much more data to determine the potential of these drugs. We are years away from solid evidence underpinning their use to treat Alzheimer's disease, for instance. There's a chance they won't do what scientists hope.

Researchers sometimes tell me that we're living through the great Ozempic experiment.

Hundreds of thousands of people across the globe are taking GLP-1s. The number will rise as they're approved for other uses. It may be years or generations before we know their hidden limitations -- or their full powers.

For more

A sad, but predictable, follow up to my post last July about the horrible side effects some patients were experiencing as a result of using the medication, inc. "gastroparesis" (stomach paralysis) ..

https://www.aol.com/dozens-sue-saying-ozempic-other-15494724 4.html

What think you? Possibly effective, or just another attempt to grab at the desperation of the obese population?

https://www.aol.com/news/vibrating-weight-loss-pill-could-09 3002998.html

Thanks! Looks like "a good time was had by all". Curious to see though how underrepesented we guys were there this year .. It appears we made up like less than 10% of the attendees .. (?) Makes me wonder now about the gender breakdown of WLSers of late, and whether the stats are that far apart there as well .. Btw, wish the pics had some captions, so we could tell who the people were in them, what they were doing at the time of the pic, etc.

Yes, I would recommend same, given your super size/BMI .. In fact, for safety reasons, the surgeon may want to make it a two-parter (V.S.G. performed first, then return later for the "common channel" work) .. Also, you might want to look into the S.A.D.I. version of the procedure .. I have been hearing some good things about it of late (e.g. avoiding malabsorption complications), and, if I had it to do over again 17 years ago (it wasn't around back then), may have gone with same myself.

So how did the conference go? Was it well attended? I haven't heard a single word .. btw, looks like I missed it, as for some reason I was thinking it was going to be in October, not September (and just a few days before my b.d., no less - how could i forget that? ) ..